Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today reinforced its global commitment to the critical work of developing antibiotics for serious infections caused by multidrug-resistant bacteria, which the company will highlight during the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), being held September 10 – 13, 2013 in Denver.
Help employers find you! Check out all the jobs and post your resume.
